Sitagliptin 50mg + Metformin Hydrochloride IP 500mg is a combination oral antidiabetic medication designed to manage type 2 diabetes mellitus. Sitagliptin works as a DPP-4 inhibitor, enhancing the levels of incretin hormones which regulate glucose by stimulating insulin release and reducing glucagon levels. Metformin hydrochloride improves insulin sensitivity, decreases hepatic glucose production, and supports better glycemic control. This combination offers a dual mechanism to help maintain stable blood sugar levels, reduce post-meal glucose spikes, and improve overall diabetes management.
